Antenatal corticosteroid treatment and infectious diseases in children: a nationwide observational study

BACKGROUND: Antenatal Corticosteroid Treatment (ACT) improves the outcome of preterm infants, but may influence immune system development and risk of immune-related diseases. We investigated whether ACT is associated with infectious diseases in children born at term (≥37 gestational weeks), and very...

Descripción completa

Detalles Bibliográficos
Autores principales: Räikkönen, Katri, Gissler, Mika, Kajantie, Eero, Tapiainen, Terhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583166/
https://www.ncbi.nlm.nih.gov/pubmed/37860637
http://dx.doi.org/10.1016/j.lanepe.2023.100750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583166/
https://www.ncbi.nlm.nih.gov/pubmed/37860637
http://dx.doi.org/10.1016/j.lanepe.2023.100750

Ejemplares similares